Molecular impacts of antisense complementary to the liver fatty acid binding protein (FABP) mRNA in DU 145 prostate cancer cells in vitro

Journal of Experimental Therapeutics and Oncology

Volumn 4, Issue 3, 2004, Pages 195-202

  Hammamieh, Rasha ^a   Chakraborty, Nabarun ^a   Das, Rina ^a   Jett, Marti ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Antisense therapy; Apoptosis; Cytokines; Molecular factors; Prostrate cancer

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; FATTY ACID BINDING PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FABP GENE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE CULTURE; UPREGULATION;

ANTIGENS, DIFFERENTIATION; APOPTOSIS; CARRIER PROTEINS; CELL PROLIFERATION; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; GENE EXPRESSION PROFILING; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES, ANTISENSE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 9344251692     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Tipping, E. and Ketterer, B. The influence of soluble binding proteins on lipophile transport and metabolism in hepatocytes. Biochem J, 195: 441-452., 1981.
2. Karmali, R. A. n-3 fatty acids and cancer. J Intern Med Suppl, 225: 197-200, 1989.
3. Grammatikos, S. I., Subbaiah, P. V., Victor, T. A., and Miller, W. M. n-3 and n-6 fatty acid processing and growth effects in neoplastic and non-cancerous human mammary epithelial cell lines. Br J Cancer, 70: 219-227, 1994.
4. Rose, D. P. and Hatala, M. A. Dietary fatty acids and breast cancer invasion and metastasis. Nutr Cancer, 21: 103-111, 1994.
5. Moore, N. G., Wang-Johanning, F., Chang, P. L., and Johanning, G. L. Omega-3 fatty acids decrease protein kinase expression in human breast cancer cells. Breast Cancer Res Treat, 67: 279-283., 2001.
6. Chamras, H., Ardashian, A., Heber, D., and Glaspy, J. A. Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation. J Nutr Biochem, 13: 711-716., 2002.
7. Bass, N. M. The cellular fatty acid binding proteins: aspects of structure, regulation, and function. Int Rev Cytol, 111: 143-184, 1988.
8. Veerkamp, J. H., van Moerkerk, H. T., Prinsen, C. F., and van Kuppevelt, T. H. Structural and functional studies on different human FABP types. Mol Cell Biochem, 192: 137-142., 1999.
9. Sohmiya, K., Tanaka, T., Tsuji, R., Yoshimoto, K., Nakayama, Y., Hirota, Y., Kawamura, K., Matsunaga, Y., Nishimura, S., and Miyazaki, H. Plasma and urinary heart-type cytoplasmic fatty acid-binding protein in coronary occlusion and reperfusion induced myocardial injury model. J Mol Cell Cardiol, 25: 1413-1426., 1993.
10. Rasmussen, H. H., Orntoft, T. F., Wolf, H., and Celis, J. E. Towards a comprehensive database of proteins from the urine of patients with bladder cancer. J Urol, 155: 2113-2119., 1996.
11. Van Nieuwenhoven, F. A., Kleine, A. H., Wodzig, W. H., Hermens, W. T., Kragten, H. A., Maessen, J. G., Punt, C. D., Van Dieijen, M. P., Van der Vusse, G. J., and Glatz, J. F. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation, 92: 2848-2854., 1995.
12. Veerkamp, J. H., Peeters, R. A., and Maatman, R. G. Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochim Biophys Acta, 1081: 1-24., 1991.
13. Sorof, S. Modulation of mitogenesis by liver fatty acid binding protein. Cancer Metastasis Rev, 13: 317-336., 1994.
14. Khan, S. H. and Sorof, S. Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators. Proc Natl Acad Sci U S A, 91: 848-852., 1994.
15. Keler, T. and Sorof, S. Growth promotion of transfected hepatoma cells by liver fatty acid binding protein. J Cell Physiol, 157: 33-40., 1993.
16. Custer, R. P. and Sorof, S. Target polypeptide of a carcinogen is associated with normal mitosis and carcinogen-induced hyperplasias in adult hepatocytes. Proc Natl Acad Sci U S A, 81: 6738-6742., 1984.
17. Grosse, R., Boehmer, F. D., Langen, P., Kurtz, A., Lehmann, W., Mieth, M., and Wallukat, G. Purification, biological assay, and immunoassay of mammary-derived growth inhibitor. Methods Enzymol, 198: 425-440, 1991.
18. Huynh, H., Alpert, L., and Pollak, M. Silencing of the mammary-derived growth inhibitor (MDGI) gene in breast neoplasms is associated with epigenetic changes. Cancer Res, 56: 4865-4870., 1996.
19. Celis, J. E., Ostergaard, M., Basse, B., Celis, A., Lauridsen, J. B., Ratz, G. P., Andersen, I., Hein, B., Wolf, H., Orntoft, T. F., and Rasmussen, H. H. Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas. Cancer Res, 56: 4782-4790., 1996.
20. Chaudry, A. A. and Dutta-Roy, A. K. Purification and characterization of a fatty acid binding protein from human prostatic tissue. Lipids, 28: 383-388, 1993.
21. Das, R., Hammamieh, R., Neill, R., Melhem, M., and Jett, M. Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues. Clin Cancer Res, 7: 1706-1715., 2001.
22. Khan, S. H. and Sorof, S. Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen. Proc Natl Acad Sci U S A, 87: 9401-9405., 1990.
23. Wolfrum, C., Borchers, T., Sacchettini, J. C., and Spener, F. Binding of fatty acids and peroxisome proliferators to orthologous fatty acid binding proteins from human, murine, and bovine liver. Biochemistry, 39: 1469-1474., 2000.
24. Josephson, R., Muller, T., Pickel, J., Okabe, S., Reynolds, K., Turner, P. A., Zimmer, A., and McKay, R. D. POU transcription factors control expression of CNS stem cell-specific genes. Development, 125: 3087-3100., 1998.
25. Wolfrum, C., Ellinghaus, P., Fobker, M., Seedorf, U., Assmann, G., Borchers, T., and Spener, F. Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein. J Lipid Res, 40: 708-714., 1999.
26. Maatman, R. G., Degano, M., Van Moerkerk, H. T., Van Marrewijk, W. J., Van der Horst, D. J., Sacchettini, J. C., and Veerkamp, J. H. Primary structure and binding characteristics of locust and human muscle fatty-acid-binding proteins. Eur J Biochem, 221: 801-810., 1994.
27. van Breda, E., Keizer, H. A., Vork, M. M., Surtel, D. A., de Jong, Y. F., van der Vusse, G. J., and Glatz, J. F. Modulation of fatty-acid-binding protein content of rat heart and skeletal muscle by endurance training and testosterone treatment. Pflugers Arch, 421: 274-279., 1992.
28. Woodford, J. K., Behnke, W. D., and Schroeder, F. Liver fatty acid binding protein enhances sterol transfer by membrane interaction. Mol Cell Biochem, 152: 51-62., 1995.
29. Poirier, H., Braissant, O., Niot, I., Wahli, W., and Besnard, P. 9-cis-retinoic acid enhances fatty acid-induced expression of the liver fatty acid-binding protein gene. FEBS Lett, 412: 480-484, 1997.
30. Ostergaard, M., Rasmussen, H. H., Nielsen, H. V., Vorum, H., Omtoft, T. F., Wolf, H., and Celis, J. E. Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res, 57: 4111-4117, 1997.
31. Murray, G. I., McKay, J. A., Weaver, R. J., Ewen, S. W., Melvin, W. T., and Burke, M. D. Cytochrome P450 expression is a common molecular event in soft tissue sarcomas. J Pathol, 171: 49-52., 1993.
32. Delmer, A., Tang, R., Senamaud-Beaufort, C., Paterlini, P., Brechot, C., and Zittoun, R. Alterations of cyclin-dependent kinase 4 inhibitor (p16INK4A/MTS1) gene structure and expression in acute lymphoblastic leukemias. Leukemia, 9: 1240-1245, 1995.
33. Rocco, J. W. and Sidransky, D. p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res, 264: 42-55, 2001.
34. Kannan, K., Amariglio, N., Rechavi, G., and Givol, D. Profile of gene expression regulated by induced p53: connection to the TGF-beta family. FEBS Lett, 470: 77-82., 2000.
35. Richieri, G. V., Ogata, R. T., Zimmerman, A. W., Veerkamp, J. H. and Kleinfeld, A. M. Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions. Biochemistry, 2000. 39 (24): p. 7197-204.
36. DeSantis, M., Hammamieh, R., Das, R. and Jett, M., Adipocyte-fatty acid binding protein induces apoptosis in DU145 prostate cancer cells, J Exp Ther Oncol, 4:91-100, 2004.